4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000104
SVP & Chief Accounting Officer sold 223 shares at $486.35 ($108,456)
- SVP & Chief Accounting Officer gave up 546 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ambrose Kristen · SVP & Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −546 | $485.11 | $264,870 | 7,204 | D |
| 2026-02-25 | Sale : show line 2 in the form 10b5-1 | −223 | $486.35 | $108,456 | 6,981 | D |
| Open-market sales · 223 sh · avg $486.35 · $108,456 | ||||||
Loading xslF345X05/wk-form4_1772146579.xml…